Ifrah Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$756K Sell
6,848
-126
-2% -$12.2K 0.19% 87
2026
Q2
$546K Sell
6,974
-55
-0.8% -$3.75K 0.13% 115
2026
Q1
$454K Buy
+7,029
New +$496K 0.12% 118
2024
Q1
– Sell
-6,060
Closed -$224K – 220
2023
Q4
$224K Sell
6,060
-371
-6% -$14K 0.07% 195
2023
Q3
$246K Sell
6,431
-66
-1% -$2.7K 0.08% 176
2023
Q2
$234K Sell
6,497
-90
-1% -$3.07K 0.07% 186
2023
Q1
$252K Sell
6,587
-164
-2% -$7.69K 0.08% 170
2022
Q4
$384K Sell
6,751
-271
-4% -$13.9K 0.13% 131
2022
Q3
$278K Sell
7,022
-26
-0.4% -$1.15K 0.1% 153
2022
Q2
$310K Buy
+7,048
New +$305K 0.1% 148

Other funds holding HALO

Ifrah Financial Services's HALO Position: Q3 2026 in Review

Ifrah Financial Services reduced its Halozyme (HALO) stake by 1.8% in Q3 2026, selling an estimated $12.2K and leaving 6,848 shares worth $756K. The position accounts for 0.19% of the portfolio, ranked #87.

Ifrah Financial Services first reported a position in HALO in Q2 2022 and has held it in 10 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Ifrah Financial Services held 6,848 shares of Halozyme worth $756K as of Q3 2026.
  • Ifrah Financial Services sold 126 Halozyme shares in Q3 2026, an estimated $12.2K.
  • Halozyme made up 0.19% of Ifrah Financial Services's portfolio in Q3 2026, its #87 holding.
  • Ifrah Financial Services first reported a position in Halozyme in Q2 2022 and has held it in 10 quarters since.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Ifrah Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.